Mostrando 5 resultados de: 5
Subtipo de publicación
Article(5)
Publisher
BMJ Open(1)
Global Health Action(1)
International Journal of Environmental Research and Public Health(1)
Journal of Evaluation in Clinical Practice(1)
Lancet Regional Health - Americas(1)
Área temáticas
Problemas sociales y servicios a grupos(3)
Medicina forense; incidencia de enfermedades(2)
Medicina y salud(2)
Educación(1)
Enfermedades(1)
Origen
scopus(5)
Bridging the gap between clinical practice and diagnostic clinical epidemiology: Pilot experiences with a didactic model based on a logarithmic scale
ArticleAbstract: Rationale: From general practitioners to academic staff, clinicians continue to have difficulties inPalabras claves:Bayes' theorem, Clinical epidemiology, Clinical reasoning, Didactic model, Likelihood ratioAutores:Bisoffi Z., Derese A., Janssen P., Juan Martín Moreira, Lynen L., Van Den Ende J., Van Der Stuyft P., Van Gompel A., Van Puymbroek H.Fuentes:scopusGaps in Hypertension Management in a Middle-Income Community of Quito-Ecuador: A Population-Based Study
ArticleAbstract: Optimal hypertension care and control at population level significantly reduces cardiovascular morbiPalabras claves:ECUADOR, health systems, Hypertension, hypertension management, Primary Health CareAutores:Agudelo E.L., Esperanza Arévalo, Patricia Ortiz, Van Der Stuyft P., Yajaira VásquezFuentes:scopusOut-of-pocket expenditure for hypertension care: a population-based study in low-income urban Medellin, Colombia
ArticleAbstract: Background: Hypertension requires life-long medical care, which may cause economic burden and even lPalabras claves:catastrophic health expenditure, Chronic Diseases, Health equity, health insurance, household budgets, Latin America, Out-of-pocket expenses, Primary Health CareAutores:Battaglioli T., García Fariñas A., Gómez-Arias R., Londoño Agudelo E.A., Pérez Ospina V., Taborda Pérez C., Tatiana Margarita Villacres Landeta, Van Der Stuyft P.Fuentes:scopusSafety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial
ArticleAbstract: Background: SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoiPalabras claves:Conjugate-vaccine, COVID-19 Vaccine, Heterologous scheme, RBD-subunit vaccine, SARS-COV-2, Vaccine efficacyAutores:Bacallao-Castillo J.P., Baldoquín-Rodríguez W., Biglari A., Caballero-González E., Climent-Ruiz Y., Doroud D., Duartes-González R., Egües-Torres L., Fernández-Castillo S., Fonte-Galindo O., García-Blanco S., García-Carmenate M., García-Rivera D., González-Mujica Romero R., Gouya M.M., Herrera-Marrero N., Huete-Ferreira S., Idalmis-Cisnero K., Licea-Martín E., Martínez-Pérez M., Meliá-Pérez D., Mendoza-Hernández I., Misladys Rodríguez Ortega, Paredes-Moreno B., Pérez-Cabrera S., Rodríguez-González M., Rojas-Remedios I., Samón-Tabio O., Toledo-Romani M.E., Valdes-Balbín Y., Valenzuela-Silva C.M., Van Der Stuyft P., Velazco-Villares P., Verez-Bencomo V.Fuentes:scopusProtocol for a controlled before-after quasi-experimental study to evaluate the effectiveness of a multi-component intervention to reduce gaps in hypertension care and control in low-income communes of Medellin, Colombia
ArticleAbstract: Introduction Research on public health interventions to improve hypertension care and control in lowPalabras claves:Hypertension, Organisation of health services, PREVENTIVE MEDICINE, PRIMARY CARE, PUBLIC HEALTHAutores:Aguilar Ramírez H., Battaglioli T., Gómez-Arias R., Londoño Agudelo E.A., Patricia Ortiz Solórzano, Pérez D., Pérez Ospina V., Rodríguez Salvá A., Soto A., Van Der Stuyft P., Vásquez Gómez J.Fuentes:scopus